DOT or not? Direct observation of anti-tuberculosis treatment and patient outcomes, Kerala State, India

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 5, 2000, Pages 409-413

  Balasubramanian, V N ^a   Oommen, K ^a   Samuel, Reuben ^b  

^a District Tuberculosis Centre   (India)

^b CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Directly observed treatment; DOTS; India; Non compliance; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; OBSERVATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT OUTCOME; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; COMMUNICABLE DISEASE CONTROL; CONFIDENCE INTERVALS; DISEASE OUTBREAKS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NATIONAL HEALTH PROGRAMS; PATIENT COMPLIANCE; PROBABILITY; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TREATMENT REFUSAL; TUBERCULOSIS;

EID: 0034021475     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. World Health Organization. Report on the tuberculosis epidemic, 1997. WHO/TB/97.224. Geneva: WHO, 1998.
2. World Health Organization. Treatment of tuberculosis. Guidelines for national programmes. 2nd ed. WHO/TB/97.220. Geneva: WHO, 1997.
3. Uplekar M, Walley J, Newell J. Directly observed treatment of tuberculosis. Lancet 1999; 353: 145.
4. Lienhardt C, Rowley J, Manneh K. Directly observed treatment of tuberculosis. Lancet 1999; 353: 145-146.
5. Frieden T R. Directly observed treatment of tuberculosis. Lancet 1999; 353: 146.
6. Harries A D, Salaniponi F M, Kwanjana J H. Directly observed treatment of tuberculosis. Lancet 1999; 353: 146-147.
7. Kochi A. Directly observed treatment of tuberculosis. Lancet 1999; 353: 147-148.
8. Zwarenstein M. Directly observed treatment of tuberculosis. Lancet 1999; 353: 145.
9. Revised National Tuberculosis Control Programme, Government of India. Technical Guidelines. New Delhi: Government of India, 1997.
10. Sbarbaro J A. The patient-physician relationship: compliance revisited. Ann Allergy 1990; 64: 326-332.
11. Chaulk C P, Kazandjian V A. Directly Observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel [published erratum appears in JAMA 1998; 280: 134]. JAMA 1998; 279: 943-948.
12. Zwarenstein M, Schoeman J H, Vundule C, Lombard C J, Tatley M. Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet 1998; 352: 1340-1343.
13. Hong Kong Chest Service/British Medical Research Council. Five-year follow-up of a controlled tria of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis 1987; 136: 1339-1342.
14. Singapore Tuberculosis Service/British Medical Research Council. Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Am Rev Respir Dis 1988: 137: 1147-1150.
15. Cohn L D, Catlin B J, Peterson K L, Judson F N, Sbarbaro J A. A 62-dose, 6-month therapy for pulmonary and extra pulmonary tuberculosis. Ann Intern Med 1990; 112: 407-415.
16. World Health Organization. Global tuberculosis control. WHO Report 1998. WHO/TB/98.237. Geneva: WHO, 1998.
17. Jagota P, Chandrasekharan S, Sumathi G. Follow-up of pulmonary tuberculosis patients treated with short course chemotherapy through traditional birth attendants. Indian J Tuberc 1998; 45: 89-93.
18. Wilkinson D. High-compliance tuberculosis treatment programme in a rural community. Lancet 1994; 343: 647-648.
19. Chowdhury A M R, Chowdhury S, Islam M N, Islam A, Vaughan J P. Control of tuberculosis by community health workers in Bangladesh. Lancet 1997; 350: 169-172.
20. Manalo F, Tan F, Sbarbaro J A, Iseman M D. Community-based short-course treatment of pulmonary tuberculosis in a developing nation. Initial report of an eight-month, largely intermittent regimen in a population with a high prevalence of drug resistance. Am Rev Respir Dis 1990; 142: 1301-1305.
21. Rajeswari R, Chandrasekaran K, Thiruvalluvan E, et al. A study on the feasibility of involving male student volunteers in case holding in an urban tuberculosis programme. Int J Tuberc Lung Dis 1997; 1: 573-575.
22. Murray C J L, DeJonghe E, Chum H J, Nyangulu D S, Salomao A, Styblo K. Cost-effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries. Lancet 1991; 338: 1305-1308.